SCHEMBL184015

SCHEMBL184015

[C]1N=Nc2ccccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5487950 0.62
SCHEMBL30373279 0.62
SCHEMBL454701 0.58
SCHEMBL237481 0.55
SCHEMBL29767688 0.55 CYP2A6 (0.36)
SCHEMBL9148625 0.55 CYP2A6 (0.36)
SCHEMBL8058639 0.55 CYP2A6 (0.36)
SCHEMBL205284 0.55
SCHEMBL8776016 0.55 CYP2A6 (0.36)
SCHEMBL11725959 0.55 LMNA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107619391-B Heterocyclic compound and organic light-emitting device including the same 三星显示有限公司 2022-08-05 CN claimed
CN-107342366-B Organic light emitting device 三星显示有限公司 2021-10-15 CN claimed
US-20150366885-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP (US) 2015-12-24 US claimed
EP-2118077-B1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP (US) 2014-12-24 EP claimed
US-20140296186-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY LSI FINANCING LLC, AS ADMINISTRATIVE AGENT 2014-10-02 US claimed
US-20140288301-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP (US) 2014-09-25 US claimed
EP-2328893-B1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP (US) 2013-03-20 EP claimed
US-8362055-B2 Triazole compounds that modulate HSP90 activity SYNTA PHARMACEUTICALS, INC. (US) 2013-01-29 US claimed
US-8318790-B2 Triazole compounds that modulate HSP90 activity SYNTA PHARMACEUTICALS CORP. (US) 2012-11-27 US claimed
EP-1817295-B1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP (US) 2012-11-07 EP claimed
WO-2006055760-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2006-05-26 WO claimed
US-7037905-B2 Pharmaceutical use of boronic acids and esters thereof NOVO NORDISK A/S (DK) 2006-05-02 US claimed
US-20040053889-A1 Pharmaceutical use of boronic acids and esters thereof NOVO NORDISK A/S (DK) 2004-03-18 US claimed
WO-2003105860-A1 PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF NOVO NORDISK A/S (DK) 2003-12-24 WO claimed
EP-0136847-B1 PHOTOGRAPHICALLY USEFUL CHALCOGENAZOLYLIDENE AND CHALCOGENAZOLIUM DYES AND METHODS FOR THEIR PREPARATION EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1990-01-17 EP claimed
US-4874866-A AROMATIC TELLURIUM-NITROGEN COMPOUNDS; DYES EASTMAN KODAK COMPANY (US) 1989-10-17 US claimed
EP-0138362-B1 PHOTOGRAPHIC MATERIALS CONTAINING CHALCOGENAZOLES, CHALCOGENAZOLINES AND CHALCOGENAZOLINIUM AND CHALCOGENAZOLIUM SALTS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1989-02-22 EP claimed
US-4576905-A Photographically useful chalcogenazoles, chalcogenazolines, and chalcogenazolinium and chalcogenazolium salts EASTMAN KODAK COMPANY (US) 1986-03-18 US claimed
EP-0138362-A2 Photographic materials containing chalcogenazoles, chalcogenazolines and chalcogenazolinium and chalcogenazolium salts EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-04-24 EP claimed
EP-0136847-A2 Photographically useful chalcogenazolylidene and chalcogenazolium dyes and methods for their preparation EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-04-10 EP claimed